An official website of the United States government
Home
Name
Eniluracil
Alternate Names
5-Ethynyluracil
5-EU
776C85
GW-776C85
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
687296
Primary Site
Breast cancer
Histology
None
Remarks
Phase III Dihydropyrimidine dehydrogenase (DPD) inhibitor. Chemotoxic agent enhancer. It has been investigated as an adjunct to fluorouracil therapy in the treatment of colorectal, breast, and pancreatic cancer. GlaxoSmithKline.
Coding
This drug should be coded
